Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
This is a dose exploration study to assess the safety and immunogenicity of two doses of the candidate HRV vaccine at different virus concentrations in the target age group (infants approximately 2 months of age and previously uninfected with human rotavirus) and receiving concomitant administration of routine vaccinations. The study also aims at exploring the effect of unrestricted feeding on the immunogenicity of the vaccine.
Epistemonikos ID: 4070cb8e0e9060f33981c1c58aaa7055c3923136
First added on: Mar 23, 2020